PubRank

G Slama

Author PubWeight™ 86.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 2004 2.77
2 Glycaemic index methodology. Nutr Res Rev 2005 2.47
3 Early closure of European Pimagedine trial. Steering Committee. Safety Committee. Lancet 1997 2.28
4 Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study Group. Diabetes Metab 1997 1.82
5 Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabete Metab 1990 1.64
6 Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. Diabetes Metab 2009 1.56
7 Correlation between amount of carbohydrate in mixed meals and insulin delivery by artificial pancreas in seven IDDM subjects. Diabetes Care 1989 1.50
8 Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy. Brain 1983 1.43
9 Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study. N Engl J Med 1992 1.41
10 Type I and type IV allergy to the insulin analogue detemir. Lancet 2007 1.41
11 Non food-related environmental stimuli induce increased meal intake in healthy women: comparison of television viewing versus listening to a recorded story in laboratory settings. Appetite 2004 1.28
12 Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab 2003 1.19
13 Three cases of allergic reaction to human insulin. Lancet 1983 1.14
14 A review of the metabolic syndrome. Diabetes Metab 2007 1.12
15 Health benefits of low glycaemic index foods, such as pulses, in diabetic patients and healthy individuals. Br J Nutr 2002 1.11
16 Effects of long-term low-glycaemic index starchy food on plasma glucose and lipid concentrations and adipose tissue cellularity in normal and diabetic rats. Br J Nutr 1996 1.09
17 The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks. Diabet Med 1992 1.04
18 A high glycemic index starch diet affects lipid storage-related enzymes in normal and to a lesser extent in diabetic rats. J Nutr 1998 1.04
19 Dietary amylose-amylopectin starch content affects glucose and lipid metabolism in adipocytes of normal and diabetic rats. J Nutr 1998 1.03
20 One to five days of continuous intravenous insulin infusion on seven diabetic patients. Diabetes 1974 1.02
21 Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab 2009 1.01
22 Hypoglycaemic reactions in 172 Type 1 (insulin-dependent) diabetic patients. Diabetologia 1983 1.01
23 Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia 2002 1.00
24 Lack of detectable deleterious effects on metabolic control of daily fructose ingestion for 2 mo in NIDDM patients. Diabetes Care 1989 0.99
25 Sucrose taken during mixed meal has no additional hyperglycaemic action over isocaloric amounts of starch in well-controlled diabetics. Lancet 1984 0.98
26 Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr 2000 0.97
27 Correlation between the nature and amount of carbohydrate in meal intake and insulin delivery by the artificial pancreas in 24 insulin-dependent diabetics. Diabetes 1981 0.97
28 Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr 1996 0.96
29 Initiation of insulin treatment after 70 years of age: patient status 2 years later. Diabet Med 1991 0.96
30 French cross-cultural adaptation of the Health Utilities Indexes Mark 2 (HUI2) and 3 (HUI3) classification systems. Clinical and Economic Working Groups. Qual Life Res 1998 0.93
31 eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabet Med 2002 0.93
32 Dietary (n-3) polyunsaturated fatty acids improve adipocyte insulin action and glucose metabolism in insulin-resistant rats: relation to membrane fatty acids. J Nutr 1996 0.92
33 Effects of dietary propionate on hepatic glucose production, whole-body glucose utilization, carbohydrate and lipid metabolism in normal rats. Br J Nutr 1995 0.91
34 Satiating effect of proteins in healthy subjects: a comparison of egg albumin, casein, gelatin, soy protein, pea protein, and wheat gluten. Am J Clin Nutr 1998 0.91
35 Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes. Lancet 1988 0.90
36 Effects of chronic dietary fructose with and without copper supplementation on glycaemic control, adiposity, insulin binding to adipocytes and glomerular basement membrane thickness in normal rats. Br J Nutr 1993 0.89
37 Varying the protein source in mixed meal modifies glucose, insulin and glucagon kinetics in healthy men, has weak effects on subjective satiety and fails to affect food intake. Eur J Clin Nutr 1999 0.87
38 Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care 1998 0.87
39 Peak-time determination of post-meal glucose excursions in insulin-treated diabetic patients. Diabetes Metab 2010 0.87
40 Gastrointestinal response and plasma and urine determinations in human subjects given erythritol. Regul Toxicol Pharmacol 1996 0.86
41 [Hemoglobin A1C determination and hemoglobinopathies: problems and strategies]. Ann Biol Clin (Paris) 2000 0.86
42 An analysis, using concept mapping, of diabetic patients' knowledge, before and after patient education. Med Teach 2002 0.86
43 Regulation of glucose transport and transporter 4 (GLUT-4) in muscle and adipocytes of sucrose-fed rats: effects of N-3 poly- and monounsaturated fatty acids. Horm Metab Res 2002 0.86
44 Painful proximal diabetic neuropathy: inflammatory nerve lesions and spontaneous favorable outcome. Ann Neurol 1997 0.85
45 Plasma lipids and fatty acid synthase activity are regulated by short-chain fructo-oligosaccharides in sucrose-fed insulin-resistant rats. J Nutr 1998 0.85
46 Uncommon early-onset neuropathy in diabetic patients. J Neurol 1998 0.85
47 Chronic consumption of fresh but not heated yogurt improves breath-hydrogen status and short-chain fatty acid profiles: a controlled study in healthy men with or without lactose maldigestion. Am J Clin Nutr 2000 0.84
48 A fructose-rich diet decreases insulin-stimulated glucose incorporation into lipids but not glucose transport in adipocytes of normal and diabetic rats. J Nutr 1995 0.83
49 Sucrose or honey at breakfast have no additional acute hyperglycaemic effect over an isoglucidic amount of bread in type 2 diabetic patients. Diabetologia 1985 0.83
50 Lispro insulin is suitable for external pumps but not for implantable pumps. Diabetes Care 1998 0.82
51 Insulinemic and glycemic indexes of six starch-rich foods taken alone and in a mixed meal by type 2 diabetics. Am J Clin Nutr 1987 0.82
52 Therapeutic alliance and glycaemic control in type 1 diabetes: a pilot study. Diabetes Metab 2010 0.81
53 Negative regulation of leptin by chronic high-glycemic index starch diet. Metabolism 2000 0.81
54 A cost-benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneous injections in patients with type I diabetes. Diabetes Care 1994 0.81
55 The use of the artificial pancreas in uremic diabetic patients. Horm Metab Res Suppl 1979 0.81
56 Intranasal glucagon in the treatment of hypoglycaemic attacks in children: experience at a summer camp. Diabetologia 1992 0.80
57 Grid photocoagulation for focal diabetic macular edema with focal leaks and hard exsudates involving the peri-foveolar area. Doc Ophthalmol 1999 0.80
58 Euglycemic hyperinsulinemic clamp to assess posthepatic glucose appearance after carbohydrate loading. 2. Evaluation of corn and mung bean starches in healthy men. Am J Clin Nutr 1999 0.80
59 Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in Type 2 diabetes. Diabet Med 2001 0.80
60 Effect of baking process on postprandial metabolic consequences: randomized trials in normal and type 2 diabetic subjects. Eur J Clin Nutr 2006 0.80
61 Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients. Diabete Metab 1986 0.79
62 Plasma and urine kinetics of erythritol after oral ingestion by healthy humans. Regul Toxicol Pharmacol 1996 0.79
63 [Effect of clinical hyperthyroidism and hypothyroidism on patent diabetes. 59 cases]. Presse Med 1985 0.79
64 Plasma insulin and C-peptide levels during continuous subcutaneous insulin infusion. Diabetes Care 1980 0.79
65 Motivational effects of 12-week moderately restrictive diets with or without special attention to the Glycaemic Index of foods. Br J Nutr 2007 0.79
66 Relative sweetness of fructose compared with sucrose in healthy and diabetic subjects. Diabetes Care 1989 0.78
67 Exercise is not associated with better diabetes control in type 1 and type 2 diabetic subjects. Acta Diabetol 1992 0.78
68 Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: assessment by the artificial pancreas. Diabetologia 1982 0.78
69 Comparative effects of 6 week fructose, dextrose and starch feeding on fat-cell lipolysis in normal rats: effects of isoproterenol, theophylline and insulin. Mol Cell Biochem 1992 0.77
70 Effects of dipeptide administration on hypoglycaemic counterregulation in type 1 diabetes. Diabetes Metab 2003 0.77
71 Continuous extracorporeal monitoring of animal blood using the glucose electrode. Diabetes 1976 0.77
72 Extreme insulin resistance: clinical management by external subcutaneous insulin infusion. Diabetes Metab 1997 0.77
73 Monosodium glutamate affects mealtime food selection in diabetic patients. Appetite 1996 0.77
74 Reducing ice cream energy density does not condition decreased acceptance or engender compensation following repeated exposure. Eur J Clin Nutr 1998 0.77
75 Insufficient adaptation of hypoglycaemic threshold for cognitive impairment in tightly controlled type 1 diabetes. Diabetes Metab 2000 0.77
76 Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients. Diabete Metab 1978 0.76
77 Glycaemic and insulinaemic responses to a new hydrogenated starch hydrolysate in healthy and type 2 diabetic subjects. Diabetes Metab 2002 0.76
78 Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic Type 2 diabetic patients with oral drug failure: a cross-over study. Diabet Med 2001 0.76
79 Lack of effect of an acute ileal perfusion of short-chain fatty acids on glucose metabolism in healthy men. Am J Physiol 1996 0.76
80 Le Diabète maigre et le diabète gras. [Lean diabetes and obese diabetes. Diabet Med 1990 0.76
81 Usefulness of the hemocue blood glucose photometer in hypoglycaemic conditions. Diabet Med 1997 0.76
82 Effect of dietary fish oil on insulin action in fat cells of control and non-insulin-dependent rats. Ann N Y Acad Sci 1993 0.76
83 Multiple daily insulin injections through subcutaneously implanted needle. Lancet 1980 0.76
84 Euglycemic hyperinsulinemic clamp to assess posthepatic glucose appearance after carbohydrate loading. 1. Validation in pigs. Am J Clin Nutr 1999 0.76
85 Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721. Diabetologia 2007 0.76
86 Sex related diurnal variations in venous blood glucose and plasma insulin levels. Effects of estrogens in men. Diabetologia 1974 0.75
87 Are there any foods that are "good" for diabetic subjects? Diabetes Care 1991 0.75
88 Insulin secretion and plasma 1,25-(OH)2D after UV-B irradiation in healthy adults. Horm Metab Res 1989 0.75
89 Neither dietary fructose, dextrose nor starch modifies in vitro glycerol release by adipocytes from streptozotocin-diabetic rats. J Nutr 1992 0.75
90 Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) 1981 0.75
91 Six month administration of gelified intranasal insulin in 16 type 1 diabetic patients under multiple injections: efficacy vs subcutaneous injections and local tolerance. Diabetes Metab 2001 0.75
92 Effect of an extra intake of carbohydrate at dinner on morning after fasting plasma glucose values in types I and II diabetes. Br Med J (Clin Res Ed) 1985 0.75
93 [Pernicious anaemia associated with Hashimoto's thyroiditis, Sjögren's syndrome and chondrocalcinosis (author's transl)]. Sem Hop 1979 0.75
94 [Rapid control of glycaemia with reactive sticks. A comparative study of 5 methods (author's transl)]. Nouv Presse Med 1981 0.75
95 Insulin receptor changes in type 2 diabetes after short term insulin treatment. Horm Metab Res 1985 0.75
96 [New technics of insulin adminstration: experience of the Hotel-Dieu]. Journ Annu Diabetol Hotel Dieu 1980 0.75
97 [The normalisation of blood sugar using a non-miniaturised artifical pancreas. Application for 24 hours in 7 insulin-dependent diabetics (author's transl)]. Nouv Presse Med 1977 0.75
98 [Human insulin: therapeutic progress?]. Ann Med Interne (Paris) 1985 0.75
99 [Current methods for optimal insulin therapy]. Ann Endocrinol (Paris) 1995 0.75
100 [Analysis of compliance with blood-glucose self monitoring at home in 113 diabetic patients treated with insulin]. Diabete Metab 1984 0.75
101 Changing practices in insulin therapy in France. Diabetes Metab 2005 0.75
102 [How to prescribing Viagra in practice...]. Diabetes Metab 2000 0.75
103 [Drug therapy of type 2 diabetes with 1.26g/l fasting blood glucose (see above)]. Diabetes Metab 1999 0.75
104 The organoleptic characteristics of fructose and sucrose have no differential influence on their consumption by healthy subjects. Physiol Behav 1989 0.75
105 Symptoms, hormones, and glucose fluxes during a gradual hypoglycaemia induced by intraperitoneal vs venous insulin infusion in Type I diabetes. Diabet Med 1995 0.75
106 [Influence of fructose on erythrocyte insulin receptors in obese diabetics and non-diabetics]. Journ Annu Diabetol Hotel Dieu 1986 0.75
107 [Volatile fatty acids. Effect on glucose metabolism?]. Rev Prat 1994 0.75
108 [Severe arterial hypertension, stenosis of the renal artery, a disorder of glycoregulation and the contraceptive pill]. Coeur Med Interne 1970 0.75
109 [Results of in vitro and in vivo use of a prototype implantable glucose sensor]. Journ Annu Diabetol Hotel Dieu 1976 0.75
110 Artificial pancreas for renal transplantation in a diabetic. Lancet 1978 0.75
111 [Artificial pancreases]. Nouv Presse Med 1977 0.75
112 A sophisticated programmable miniaturised pump for insulin delivery. Med Prog Technol 1980 0.75
113 [Prospects in the treatment of insulin-dependent diabetics]. Rev Prat 1981 0.75
114 Study of glucagon secretion using in vitro perifusion of rat pancreas pieces. Diabete Metab 1975 0.75
115 [Sex differences in the blood glucose fall induced by short fasts (author's transl)]. Diabete Metab 1976 0.75
116 [Do simple sugars have a place in the diabetic diet?]. Journ Annu Diabetol Hotel Dieu 1985 0.75
117 [Insulin therapy in aged patients]. Journ Annu Diabetol Hotel Dieu 1986 0.75
118 Comparison between a rapid glycohaemoglobin (HbA1c) immunoassay and other indices of glycaemic control. Acta Diabetol 1996 0.75
119 [Erythrocyte aggregation in vascular disease. Influence++ of hypertension]. J Mal Vasc 1991 0.75
120 Quantification of early subclinical limited joint mobility in diabetes mellitus. Diabetes Care 1985 0.75
121 [Effects of oral TRH on the thyroid function, thyrotropin and prolactin secretion, in 9 normal subjects]. Ann Endocrinol (Paris) 1975 0.75
122 [Clinical management of a diabetic patient treated with an implantable insulin pump]. Diabete Metab 1992 0.75
123 Preprandial intranasal insulin as adjuvant therapy in type II diabetics. Lancet 1987 0.75
124 [Paraclinical tests in adult diabetes and hypoglycemia]. Rev Prat 1980 0.75
125 An aged people is wandering in the desert of ignorance: the land of elderly patients with diabetes mellitus. Diabetes Metab 2005 0.75
126 Insulin and glycemic responses in healthy humans to native starches processed in different ways: correlation with in vitro alpha-amylase hydrolysis. Am J Clin Nutr 1989 0.75
127 Prevalence of end-stage renal failure and severe retinopathy in type 2 diabetes. Lancet 1992 0.75
128 Therapeutic trials in Type 1 (insulin-dependent) diabetic patients on insulin: goals and tools. Diabetologia 1983 0.75
129 Efficacy and indications of CSII revisited: the Hotel-Dieu cohort. Diabet Med 1997 0.75
130 Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD. Proc Clin Dial Transplant Forum 1980 0.75
131 [Hyperglycemic agents]. Pathol Biol (Paris) 1986 0.75
132 [Possible consequences on the follow up of type 2 diabetic patients of a recent modification of a glycosylated hemoglobin assay]. Diabetes Metab 1999 0.75
133 Evaluation of a structured 4-day educational programme for intensive insulin therapy. Diabet Med 1997 0.75
134 Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes. Diabetes Metab 2011 0.75
135 [Attempt at prolonged stimulation of adrenocortical insufficiency by long-acting beta-1-24-corticotrophin]. Rev Fr Endocrinol Clin 1973 0.75
136 [Low calorie substitutes in the diabetic diet]. Journ Annu Diabetol Hotel Dieu 1993 0.75
137 [Effect of fermentation products of dietary fiber--short-chain fatty acids--on glucose and lipid metabolism]. Journ Annu Diabetol Hotel Dieu 1993 0.75
138 [Current role of external pumps in the treatment of insulin-dependent diabetes mellitus]. Diabete Metab 1995 0.75
139 [The night of the insulin-dependent diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabetes Metab 1996 0.75
140 [Diagnostic and decision-making process when confronted with a patient suspected of organic hypoglycemia]. Journ Annu Diabetol Hotel Dieu 1983 0.75
141 Laboratory diagnosis of HIV infection in Papua New Guinea. P N G Med J 1996 0.75
142 [Conception and contraception in diabetics]. Rev Prat 1986 0.75
143 [Cost benefits of intensive insulin therapy using injections, external pumps and implantable pumps]. Diabete Metab 1993 0.75
144 [Flat curves of oral glucose tolerance tests (author's transl)]. Nouv Presse Med 1980 0.75
145 [Is glycosylated haemoglobin subject to rapid variations? Changes in insulin-dependent diabetic patients under a 24-hour artificial pancreas treatment (author's transl)]. Nouv Presse Med 1981 0.75
146 Reduction of post-prandial insulin needs by pectin as assessed by the artificial pancreas in insulin-dependent diabetics. Diabete Metab 1982 0.75
147 [Contribution to a critical re-examination of the nutrition advice given to diabetic patients]. Journ Annu Diabetol Hotel Dieu 1989 0.75
148 Clinical manifestations of HIV infection in Melanesian adults. P N G Med J 1996 0.75
149 [Rapid determination of blood sugar using Dextrostix reactive strips and the reflectance meter]. Pathol Biol (Paris) 1974 0.75
150 [Hypoglycemia in the diabetic patient. Recommendations of ALFEDIAM]. Diabetes Metab 1997 0.75
151 Bedside estimation of microalbuminuria. Lancet 1985 0.75
152 [Lispro (humalog) insulin in practice]. Diabetes Metab 1998 0.75
153 HBA1c: clinical and biological agreement for standardization of assay methods. Report by the experts of ALFEDIAM (Association de Langue Française pour lEtude du Diabète et des Maladies Métabolique) and SFBC (Société Française de Biologie Clinique). Diabetes Metab 1999 0.75
154 [Adaptation of insulin therapy in the evening and/or at bedtime. Experience of night hospitalization]. Journ Annu Diabetol Hotel Dieu 1996 0.75
155 The French paradox and diabetic patients. Diabetes Care 1997 0.75
156 [Significance of blood sugar normalization in the prevention of vascular complications in diabetes mellitus]. Rev Prat 1976 0.75
157 [What are the means for limiting the increased risk of hypoglycemia during intensive insulin therapy?]. Journ Annu Diabetol Hotel Dieu 1994 0.75
158 Frequent outpatient follow-up improves severe hypoglycaemia and moderate hyperglycaemia in insulin-dependent diabetic patients. Diabetes Metab 1997 0.75
159 Lifestyle, metabolic control and social implications of pump therapy in 54 routine type I diabetic patients. Diabete Metab 1987 0.75
160 [Administration of insulin in type 1 diabetes]. Rev Prat 1992 0.75
161 [Erythrocyte insulin receptors technics and clinical applications]. Journ Annu Diabetol Hotel Dieu 1982 0.75
162 Intranasal glucagon for hypoglycaemia. Lancet 1988 0.75
163 [Severe forms of diabetic neuropathies]. Journ Annu Diabetol Hotel Dieu 1978 0.75
164 [The insulin pump in ambulatory diabetic therapy]. Rev Med Suisse Romande 1984 0.75
165 [Diabetic instability and eating disorders]. Journ Annu Diabetol Hotel Dieu 1995 0.75
166 [Nutrition and diabetes. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabete Metab 1995 0.75
167 Methods to assess glucose metabolism in humans in relation to carbohydrate and fibre in the diet. Eur J Clin Nutr 1995 0.75
168 [Diabetic retinopathy and growth hormone secretion in 39 non insulin-dependant diabetic patients]. Nouv Presse Med 1973 0.75
169 Influence of concentration on the kinetics of SC-infused insulin. Comparison between square-wave SC infusion and bolus SC injection. Metabolism 1985 0.75
170 [How to advance antidiabetic therapy]. Nouv Presse Med 1974 0.75
171 [Ambulatory self-instruction of diabetic patients: a model of therapeutic education]. Journ Annu Diabetol Hotel Dieu 2006 0.75
172 [1990 diabetes workshop at the Hôtel-Dieu hospital, Paris]. Rev Prat 1990 0.75
173 [Pathogenesis, physiopathology, and epidemiology of diabetic microangiopathy]. Rev Prat 1976 0.75
174 [Sugar for diabetic patients? Dietetic counselling for the diabetic]. Rev Prat 1985 0.75
175 [Are there indications for grafts of the pancreas?]. Ann Med Interne (Paris) 1990 0.75
176 [Considerations on delocalized HbA1c assays]. Diabetes Metab 2000 0.75
177 An analysis of the teaching techniques used in diabetic specialist consultations. Patient Educ Couns 2000 0.75
178 [Waldenström's macroglobulinemia with pleuropulmonary, orbital and subcutaneous localisation. Favorable effect of chlorambucil]. Sem Hop 1972 0.75
179 [Hypoglycemia experienced by insulin-treated diabetics]. Journ Annu Diabetol Hotel Dieu 1981 0.75
180 [A new strategy for education and management of insulin-dependent diabetics]. Diabetes Metab 1998 0.75
181 [Insulin administration systems. Possibilities and difficulties]. Presse Med 1992 0.75
182 Treatment of end-stage renal failure in the insulin-dependent diabetic patient. Adv Nephrol Necker Hosp 1979 0.75
183 [Liver abscess caused by gallbladder rupture during pyocholecystitis]. Sem Hop 1971 0.75
184 Pectin efficacy in insulin-treated diabetics assessed by the artificial pancreas. Lancet 1980 0.75